BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 37686638)

  • 1. Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach.
    Della Corte A; Santangelo D; Augello L; Ratti F; Cipriani F; Canevari C; Gusmini S; Guazzarotti G; Palumbo D; Chiti A; Aldrighetti L; De Cobelli F
    Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1703-1712. PubMed ID: 37704862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study.
    Al Taweel B; Cassese G; Khayat S; Chazal M; Navarro F; Guiu B; Panaro F
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893103
    [No Abstract]   [Full Text] [Related]  

  • 3. Tc-99m mebrofenin hepatobiliary scintigraphy to assess future liver remnant function before major liver surgery.
    Smet H; Martin D; Uldry E; Duran R; Girardet R; Schaefer N; Prior JO; Denys A; Halkic N; Demartines N; Melloul E
    J Surg Oncol; 2023 Dec; 128(8):1312-1319. PubMed ID: 37638473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIRSE Standards of Practice on Portal Vein Embolization and Double Vein Embolization/Liver Venous Deprivation.
    Bilhim T; Böning G; Guiu B; Luz JH; Denys A
    Cardiovasc Intervent Radiol; 2024 Jun; ():. PubMed ID: 38884781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein embolization with N-butyl-cyanoacrylate improves liver hypertrophy compared to microparticles - A Swedish multicenter cohort study.
    Björk D; Delle M; Holmquist F; Hasselgren K; Sandström P; Lindell G; Sparrelid E; Björnsson B
    Heliyon; 2023 Nov; 9(11):e21210. PubMed ID: 37954304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma.
    Kawano F; Yoshioka R; Ichida H; Mise Y; Saiura A
    Ann Gastroenterol Surg; 2023 Nov; 7(6):848-855. PubMed ID: 37927920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Effectiveness of Portal Vein Embolization after Hepatic Arterial Infusion Therapy.
    Li N; Schwantes IR; Mayo SC; Park B; Koethe Y
    J Vasc Interv Radiol; 2024 May; ():. PubMed ID: 38704140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA).
    Barcena AJR; Owens TC; Melancon S; Workeneh I; Tran Cao HS; Vauthey JN; Huang SY
    Stem Cell Rev Rep; 2024 Apr; ():. PubMed ID: 38613627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma.
    Ratti F; Marino R; Muiesan P; Zieniewicz K; Van Gulik T; Guglielmi A; Marques HP; Andres V; Schnitzbauer A; Irinel P; Schmelzle M; Sparrelid E; Fusai GK; Adam R; Cillo U; Lang H; Oldhafer K; Ruslan A; Ciria R; Ferrero A; Mazzaferro V; Cescon M; Giuliante F; Nadalin S; Golse N; Sulpice L; Serrablo A; Ramos E; Marchese U; Rosok B; Lopez-Lopez V; Clavien P; Aldrighetti L;
    HPB (Oxford); 2023 Nov; 25(11):1302-1322. PubMed ID: 37543473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes.
    Guiu B; Quenet F; Panaro F; Piron L; Cassinotto C; Herrerro A; Souche FR; Hermida M; Pierredon-Foulongne MA; Belgour A; Aho-Glele S; Deshayes E
    Hepatobiliary Surg Nutr; 2020 Oct; 9(5):564-576. PubMed ID: 33163507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies.
    Charles J; Nezami N; Loya M; Shube S; Davis C; Hoots G; Shaikh J
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal Vein Embolization Utilizing N-Butyl Cyanoacrylate for Contralateral Lobe Hypertrophy Prior to Liver Resection: A Systematic Review and Meta-Analysis.
    Wajswol E; Jazmati T; Contractor S; Kumar A
    Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1302-1312. PubMed ID: 29687262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy?
    Marino R; Ratti F; Della Corte A; Santangelo D; Clocchiatti L; Canevari C; Magnani P; Pedica F; Casadei-Gardini A; De Cobelli F; Aldrighetti L
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686638
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.
    Gavriilidis P; Marangoni G; Ahmad J; Azoulay D
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):221-227. PubMed ID: 36100542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Venous Deprivation (LVD) Versus Portal Vein Embolization (PVE) Alone Prior to Extended Hepatectomy: A Matched Pair Analysis.
    Böning G; Fehrenbach U; Auer TA; Neumann K; Jonczyk M; Pratschke J; Schöning W; Schmelzle M; Gebauer B
    Cardiovasc Intervent Radiol; 2022 Jul; 45(7):950-957. PubMed ID: 35314879
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.